SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-16-074960
Filing Date
2016-01-11
Accepted
2016-01-11 06:09:04
Documents
21
Period of Report
2016-01-11
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v428747_8k.htm 8-K 15027
2 EXHIBIT 99.1 v428747_ex99-1.htm EX-99.1 20920
3 GRAPHIC page_001.jpg GRAPHIC 297306
4 GRAPHIC page_002.jpg GRAPHIC 389232
5 GRAPHIC page_003.jpg GRAPHIC 213992
6 GRAPHIC page_004.jpg GRAPHIC 323610
7 GRAPHIC page_005.jpg GRAPHIC 255952
8 GRAPHIC page_006.jpg GRAPHIC 239507
9 GRAPHIC page_007.jpg GRAPHIC 212732
10 GRAPHIC page_008.jpg GRAPHIC 228969
11 GRAPHIC page_009.jpg GRAPHIC 217909
12 GRAPHIC page_010.jpg GRAPHIC 289857
13 GRAPHIC page_011.jpg GRAPHIC 339818
14 GRAPHIC page_012.jpg GRAPHIC 213691
15 GRAPHIC page_013.jpg GRAPHIC 206419
16 GRAPHIC page_014.jpg GRAPHIC 316221
17 GRAPHIC page_015.jpg GRAPHIC 235508
18 GRAPHIC page_016.jpg GRAPHIC 278279
19 GRAPHIC page_017.jpg GRAPHIC 176741
20 GRAPHIC page_018.jpg GRAPHIC 214326
21 GRAPHIC page_019.jpg GRAPHIC 233978
  Complete submission text file 0001144204-16-074960.txt   6765380
Mailing Address 800 E LEIGH ST SUITE 209 RICHMOND VA 23219
Business Address 800 E LEIGH ST SUITE 209 RICHMOND VA 23219 804-827-2524
AmpliPhi Biosciences Corp (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37544 | Film No.: 161334913
SIC: 2836 Biological Products, (No Diagnostic Substances)